HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Consumer Stays In Motion In Goody’s Ad Campaign, Gets Moving In Dramamine Sweepstakes

Executive Summary

“Get To Good” campaign features “characters who embody the Goody’s consumer, leading active lives and refusing to be slowed down by pain,” while Dramamine’s “Ditch the Drama Sweepstakes” offers “dream vacation anywhere in the world” and introduces “Drama Llama” as “spokescharacter.”  

You may also be interested in...



Dramamine, Nix Drive Prestige Consumer Sales

Consumers’ OTC drug choices extend beyond pain relievers, heartburn remedies and allergy formulations, Prestige Consumer Healthcare points out as it announces reported revenues up 0.8% to $279.3m in its latest quarter.

Prestige Consumer Not Thirsty For Bringing International Sales Leader Hydralyte To US

Expanding Hydralyte sales to US sports beverage market might seem a likely target for PCH. But firm doesn’t plan to bring its Hydralyte products to the US, where a smaller company owns and markets the brand.

Prestige Consumer’s International Cough/Cold Sales Offset FX Loss In Latest Results

Higher cough/cold OTC sales along with Hydralyte line and sore throat treatments bright spots in October-December offset by COVID-19 and continuing supply chain constraints.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel